Physicians and drug developers do not always have the same research questions. The new special programme Investigator Initiated Clinical Trials (IICT) will enable independent clinical researchers to answer questions that are important for patients.
Therapies for rare diseases, drug dose reductions and the comparisons of surgical interventions are not in the focus of the pharmaceutical industry because they lack significant commercial potential. Nevertheless, research on such treatments will greatly benefit the affected patients.
On 12 August 2015, the Swiss National Science Foundation (SNSF) will, for the first time, launch a call for a special programme that aims to support clinical studies initiated by researchers (Investigator Initiated Clinical Trials, IICT). There will be a call in 2015 and another next year, each with a maximum budget of CHF 10 million
High quality standards
"This pioneering initiative meets a major need for enhancing the profile of clinical research in Switzerland while setting high quality standards at the same time," said Aysim Yilmaz, head of the Biology and Medicine division of the SNSF Administrative Offices. To this end, the funded projects will be closely monitored and supported.
A requirement, for example, is for the relevant clinicians to make the anonymised data available to other research projects.
In line with the principles of the SNSF, only clinical studies that do not have a directly commercial purpose will be supported. However, donations from companies are not categorically ruled out as long as they do not influence the research work undertaken in the programme.
"It is not the programme's aim to place any limits on research funded by corporations, but rather to provide an impetus for increased funding of independent clinical research," Yilmaz adds.
The SNSF expects to support four to five clinical trials per year. The first batch of proposals needs to be submitted by 15 October 2015, with the corresponding funding decisions to be taken by 17 March 2016.
Tel: +41 (0)31 308 23 75
The text of this press release and the pre-announcement can be found on the website of the Swiss National Science Foundation:
http://www.snsf.ch > Research in focus > Media > Press releases
Communication | idw - Informationsdienst Wissenschaft
Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses
14.03.2017 | Goethe-Universität Frankfurt am Main
BMBF funding for diabetes research on pancreas chip
08.02.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy